[Treatment of secondary hyperaldosteronism].
D000315:Adrenalectomy; D000450:Aldosterone / Q000096:biosynthesis; D000616:Aminoglutethimide / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D000451:Mineralocorticoid Receptor Antagonists; D011728:Pyridones / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D000814:Aniline Compounds; D000927:Anticonvulsants; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D011728:Pyridones; D000616:Aminoglutethimide; D013148:Spironolactone; D000450:Aldosterone; D014223:Triamterene
Therapie des sekundären Hyperaldosteronismus.